Hilden, Germany
Coramaze Technologies, operating under the slogan "Filling the Gap," is an innovative player in the Health Care and Medical Devices industries. Established in 2013, the company is headquartered in Germany and also has offices in Israel. This clinical-stage company's primary focus is on developing cutting-edge solutions for treating tricuspid regurgitation, a condition for which alternative therapies are limited.
Their flagship product, the TriPair system, is a device that offers a unique combination of atraumatic anchoring in the right atrium, complete retrievability, and real-time procedural efficacy evaluation. The system is designed to empower physicians with a quick and effective repair solution, aimed at saving lives by transforming patient care.
Coramaze received a significant €4.50M Series A investment from Elron Ventures on 01 September 2015. This investment supports their ongoing efforts to bridge critical gaps in cardiac health care.
